Several case reports and reviews have identified G-CSF—particularly pegfilgrastim—as a potential trigger for LVV, manifesting as aortitis or arteritis, often accompanied by systemic symptoms such as fever, malaise, and elevated inflammatory markers. This evidence concerns the gene CSF3 and aortitis.